Bright Spire Capital, Inc. BRSP
We take great care to ensure that the data presented and summarized in this overview for BrightSpire Capital, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding BRSP
View all-
Vanguard Group Inc Valley Forge, PA12.3MShares$66.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.6MShares$63 Million0.0% of portfolio
-
Nut Tree Capital Management, LP New York, NY11MShares$59.6 Million16.14% of portfolio
-
Private Management Group Inc4.84MShares$26.2 Million0.78% of portfolio
-
Nomura Holdings Inc Tokyo, M03.41MShares$18.5 Million0.03% of portfolio
-
State Street Corp Boston, MA3.25MShares$17.6 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.16MShares$17.1 Million0.0% of portfolio
-
Cf Capital LLC Cohasset, MA2.52MShares$13.7 Million8.4% of portfolio
-
Goldman Sachs Group Inc New York, NY2.51MShares$13.6 Million0.0% of portfolio
-
Punch & Associates Investment Management, Inc. Edina, MN2.34MShares$12.7 Million0.82% of portfolio
Latest Institutional Activity in BRSP
Top Purchases
Top Sells
About BRSP
BrightSpire Capital, Inc. operates as a commercial real estate (CRE) credit real estate investment trust in the United States. It focuses on originating, acquiring, financing, and managing a portfolio of CRE senior mortgage loans, mezzanine loans, preferred equity, debt securities, and net leased properties. The company qualifies as a real estate investment trust for federal income tax purposes. The company was formerly known as Colony Credit Real Estate, Inc. and changed its name to BrightSpire Capital, Inc. in June 2021. BrightSpire Capital, Inc. was incorporated in 2017 and is headquartered in New York, New York.
Insider Transactions at BRSP
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 19
2025
|
Vernon B Schwartz Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,588
+13.66%
|
-
|
|
May 19
2025
|
Kim S Diamond Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,588
+20.69%
|
-
|
|
May 19
2025
|
John E Westerfield Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,588
+14.31%
|
-
|
|
May 19
2025
|
Catherine Rice Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,588
+13.58%
|
-
|
|
May 19
2025
|
Catherine F. Long Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,588
+20.95%
|
-
|
|
Mar 17
2025
|
Frank V Saracino Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
54,217
-12.64%
|
$325,302
$6.01 P/Share
|
|
Mar 17
2025
|
Frank V Saracino Officer |
BUY
Grant, award, or other acquisition
|
Direct |
110,234
+11.88%
|
-
|
|
Mar 17
2025
|
David A Palame Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
63,504
-13.84%
|
$381,024
$6.01 P/Share
|
|
Mar 17
2025
|
David A Palame Officer |
BUY
Grant, award, or other acquisition
|
Direct |
111,008
+11.18%
|
-
|
|
Mar 17
2025
|
Andrew Elmore Witt Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
86,686
-13.01%
|
$520,116
$6.01 P/Share
|
|
Mar 17
2025
|
Andrew Elmore Witt Officer |
BUY
Grant, award, or other acquisition
|
Direct |
181,033
+12.45%
|
-
|
|
Mar 17
2025
|
Michael Mazzei CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
209,820
-13.59%
|
$1,258,920
$6.01 P/Share
|
|
Mar 17
2025
|
Michael Mazzei CEO |
BUY
Grant, award, or other acquisition
|
Direct |
366,058
+11.08%
|
-
|
|
May 17
2024
|
Kim S Diamond Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,899
+23.18%
|
-
|
|
May 17
2024
|
Vernon B Schwartz Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,899
+13.85%
|
-
|
|
May 17
2024
|
Catherine Rice Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,899
+13.75%
|
-
|
|
May 17
2024
|
John E Westerfield Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,899
+14.64%
|
-
|
|
May 17
2024
|
Catherine F. Long Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,899
+23.58%
|
-
|
|
Mar 27
2024
|
David A Palame Officer |
SELL
Open market or private sale
|
Direct |
50,000
-12.57%
|
$300,000
$6.76 P/Share
|
|
Mar 15
2024
|
Frank V Saracino Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
48,057
-13.11%
|
$288,342
$6.71 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 861K shares |
|---|
| Payment of exercise price or tax liability | 414K shares |
|---|